Skip to main content

Table 1 Basic information of the subjects

From: Composition and diversity analysis of the TCR CDR3 repertoire in patients with idiopathic orbital inflammation using high-throughput sequencing

Characteristics

HC group

IOI group

IOI(EF) group

IOI(IN) group

P Value1

P Value2

P Value3

P Value4

N

6

13

6

7

-

-

-

-

Age, year

41.83 ± 12.64

43.31 ± 13.91

38.17 ± 16.71

47.71 ± 8.84

0.837

0.704

0.386

0.253

Gender, F:M

4: 2

9: 4

3:3

6:1

0.911

0.558

0.416

0.164

SE, D

-0.44 ± 1.78

-0.33 ± 1.64

-1.23 ± 1.47

0.45 ± 1.37

0.902

0.461

0.372

0.076

BCVA, LogMAR

-0.03 ± 0.04

0.34 ± 0.61

0.14 ± 0.14

0.52 ± 0.78

0.002

0.030

0.141

0.295

IOP, mmHg

15.35 ± 2.70

16.21 ± 6.28

15.28 ± 3.25

17.00 ± 7.92

0.765

0.973

0.663

0.657

Exophthalmometry, mm

13.83 ± 1.34

15.85 ± 3.53

15.50 ± 1.26

16.14 ± 4.64

0.218

0.071

0.302

0.768

CDR3 clean reads

89,791,638 ± 21,480,234

102,102,541 ± 8,705,207

97,670,963 ± 9,415,117

105,901,035 ± 5,787,281

0.264

0.470

0.108

0.104

D50

6975 ± 2103

1555 ± 824

1040 ± 738

1997 ± 609

0.002

0.001

0.003

0.038

  1. Data are presented as Mean ± SD. N, number of people; F, female; M, male; SE, spherical equivalent; BCVA, best corrected visual acuity; IOP, intraocular pressure; P value1, P value between HC group and IOI group; P value2, P value between HC group and IOI(EF) group; P value3, P value between HC and IOI(IN) group; P value4, P value between IOI(EF) and IOI(IN) group